SCHEMBL5559593

SCHEMBL5559593

Cc1ccc2c(c1)Nc1ccccc1N=C2N1CCN(C)C(CCc2cccc(F)c2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.44
DRD4 P21917 6/20 0.44
CHRM1 P11229 9/20 0.40
DRD3 P35462 3/20 0.39
DRD1 P21728 6/20 0.39
HRH1 P35367 4/20 0.39
PAK1 Q13153 1/20 0.39
CHRM2 P08172 3/20 0.39
CHRM4 P08173 3/20 0.39
CHRM5 P08912 3/20 0.39
ADRA2A P08913 3/20 0.39
ADRA2B P18089 3/20 0.39
ADRA2C P18825 3/20 0.39
CHRM3 P20309 3/20 0.39
ADRA1D P25100 3/20 0.39
HTR2A P28223 3/20 0.39
HTR2C P28335 3/20 0.39
ADRA1A P35348 3/20 0.39
ADRA1B P35368 3/20 0.39
HTR2B P41595 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5559586 1.00 DRD2 (0.44) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5559580 1.00 DRD2 (0.44) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5564895 0.91 DRD2 (0.49) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL14511110 0.86 CHRM1 (0.58) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5562521 0.85 DRD2 (0.39) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5562518 0.85 DRD2 (0.39) DRD2DRD4CHRM1DRD3DRD1
Hydrochloric Acid SCHEMBL5563439 0.85 CHRM1 (0.58) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL14511279 0.84 CHRM1 (0.44) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5288483 0.84 DRD2 (0.48) DRD2DRD4CHRM1DRD3DRD1
SCHEMBL5288472 0.84 DRD2 (0.48) DRD2DRD4CHRM1DRD3DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492794-B1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES AND THEIR USE AS DOPAMINE RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PSYCHOTIC DISORDERS LILLY CO ELI (US) 2007-12-12 EP disclosed